PCK1 and hepatocellular carcinoma: Importantly, we found that PCK1 inhibits motility of hepatoma cell via downregulating cellular O-GlcNAcylation levels by detecting the cellular motility in response to OGT or OGA inhibition (Supplementary Fig. 1c-j).